Pharmacies are halting sales of OSR#1, a compound marketed as a dietary supplement to parents of children with autism, six weeks after the U.S. Food and Drug Administration called the product an unapproved new drug. Several pharmacists told the Tribune they received an e-mail last week from Boyd Haley, president of the company that makes the product, informing them that OSR#1 would not be available after Thursday. One online pharmacy, Forrest Health, posted this message: "CTI Science has voluntarily agreed to remove OSR#1® from the market effective Thursday, 29 July 2010."
Click here for full article.
31
